Your friend just started semaglutide. She got it online; it's "compounded," it has B12 in it, and it's only $199 a month. Sounds like a great deal, right? But what exactly is in that vial, who made it, and how much are you supposed to take? More and more people are facing these questions every day, and most of us don't know how to answer them.

Join Holly and Jim as they welcome not one, not two, but three guests for the very first time: Misty Gaddis, pharmacy manager of medication compounding safety; Jessica Pescatore, clinical director of the Alabama Poison Information Center; and Richelle Chambliss, a clinical pharmacist who supports UAB's weight management clinics. Together, they pull back the curtain on compounded GLP-1s and share what your pharmacist wants you to know about weight loss medications, from dosing and side effects to insurance, access, and stopping and restarting. You'll come away with practical questions to ask and red flags to watch for before you inject anything.

Discussed on the episode:

• Why "compounded" doesn't mean "generic," and the common misconception that could put you at risk
• The real reason B12 shows up in so many online semaglutide products (and whether it's doing anything for your weight loss)
• What the Poison Center hears when dosing goes wrong, and why compounded products create a whole new level of risk
• The surprising truth about why the cheapest option may not be the cheapest for long
• A tempting shortcut to save money that pharmacists urge you not to take
• Why the "best" dose may not be the highest one
• What can happen when you stop and restart your medication on your own
• The red flags that should make you pause before taking anything you've ordered online
• The underrated ways your pharmacist can help you succeed, and when to call them
• A question Holly and Jim have never asked in decades of weight loss work, and why it's now on the table

New obesity medications can now produce weight loss once thought impossible without surgery. That success is forcing doctors to ask a question they never had to face before: what if a treatment doesn't know when to stop?

Join Holly and Jim as they unpack six new questions these next-generation drugs have raised in obesity medicine. Using a relatable patient case, they explore the difference between losing the maximum amount of weight and losing the optimal amount, and why those two things are no longer the same. You'll also hear where lifestyle fits into treatment now, what "success" really means when the scale isn't the whole story, and why the answers may ultimately come down to a conversation between patient and provider.

Discussed on the episode:

• Why hitting the weight-loss "ceiling" used to save doctors from a decision they never had to make
• A patient case that reveals what happens when someone loses more weight than she may actually need
• The hidden trade-off between the number on the scale and what's happening to muscle and strength
• Why nutrition and physical activity haven't become less important on these medications, just different
• The rapid-fire round that puts Holly and Jim on the spot with some of obesity medicine's toughest new dilemmas

If losing weight made movement easier, wouldn’t you naturally start moving more? It’s the kind of assumption that feels almost too obvious to question: shed 40 or 50 pounds, and your knees stop aching, the stairs get easier, and you’re out there living more. Holly and Jim certainly believed it. But in the age of GLP-1 medications, where rapid, substantial weight loss is now common, does this assumption still hold up?

In this episode, Holly and Jim put that belief to the test with real data. Diving into three separate studies (including brand-new, cutting-edge research), they explore what happens to physical activity levels once people start losing weight on GLP-1s. The results might surprise you, and as Jim warns early on, they might leave you feeling a little deflated too. But stick around, because Holly and Jim don’t just deliver the bad news; they explain why it matters and what you can actually do about it.

Discussed on the episode

• The surprising step-count numbers researchers found when they measured GLP-1 users with wearable devices and why the results left Jim unimpressed.
• What happened when scientists tracked the same people’s activity levels before and after starting a GLP-1 medication (hint: it wasn’t what anyone expected)
• Why a control group matters so much in this kind of research, and what’s still missing from the picture
• The difference between “free living” activity and structured exercise, and which one may be quietly declining
• A few theories on why physical activity might dip on these medications, and why even Jim isn’t fully convinced by any of them
• Five practical strategies for making sure your activity level doesn’t get left behind while the pounds come off
• Holly and Jim’s honest, personal reactions to research that challenges something they’ve believed for years

Everyone knows GLP-1 medications help people eat less. But does eating less actually mean eating better? It’s a question the weight loss field never really had to ask before, and the answer might surprise you.

Join Holly and Jim as they dig into three GLP-1 studies looking at what people are actually eating. You’ll hear the real numbers behind diet quality, protein intake, and nutrient gaps on these medications, plus what it means for anyone currently taking (or considering) a GLP-1. Holly and Jim also share five practical tips to help ensure your diet works as hard as your medication is.

Discussed on the episode

• Why losing weight on a GLP-1 doesn’t automatically mean you’re eating a healthier diet
• The surprising “Healthy Eating Index” scores researchers found in people taking these medications.
• Which micronutrients tend to slip through the cracks when food intake drops
• The protein timing pattern showing up in the data and why it might matter.
• Whether cravings actually go away on GLP-1s, or if that’s a myth
• Five things anyone on a GLP-1 can do right now to protect their diet quality
• Answers to listener questions on appetite loss, ongoing hunger, and whether there’s a “best” GLP-1 diet
• A teaser for the next episode, which flips the lens to physical activity on GLP-1s

Think you know what it takes to keep weight off? Most people can tell you how to lose weight, but ask them what actually predicts keeping it off, and the answers get shaky fast. That’s a problem, because losing weight and maintaining weight loss are two completely different biological and behavioral games, and confusing the two is one of the biggest reasons people yo-yo.

In this episode, Holly and Jim put their listeners to the test literally. They’ve built a 20-question pop quiz covering everything from the hidden biology of metabolic adaptation to the real findings from the National Weight Control Registry, the groundbreaking study Jim co-founded three decades ago. And because so much has changed recently, they’re also tackling the question everyone’s asking: does any of this still apply in the age of GLP-1 medications?

Grab a pen (or play along in your head) and see how many you get right. Some answers might surprise you, and a few might change how you think about your own weight loss journey for good.

Discussed on the episode:

• Why the biology of losing weight and the biology of keeping it off are two entirely different processes, and why not knowing this is setting you up to regain
• What really happens to your metabolism after weight loss, and whether “metabolic adaptation” is something you should actually be worried about
• The hunger hormone changes that don’t go away and what that means for your day-to-day life
• The real math behind the “energy gap,” a concept Jim and Holly coined themselves
• What the National Weight Control Registry’s 30,000+ members actually do differently, including the surprisingly unglamorous form of exercise most of them rely on
• Whether successful maintainers take weekends and holidays “off” from their habits
• The truth behind the infamous “95% of diets fail” statistic.
• Whether losing weight slowly really does make you more likely to keep it off.
• Why willpower isn’t the key predictor of long-term success and what is
• What happens to the body when someone stops taking a GLP-1 medication, and whether that counts as the medication “failing”
• The most vulnerable window for regain during medication-assisted weight loss and why most people prepare for the wrong phase
• A rapid-fire round covering daily weighing, running vs. walking, and the most overrated maintenance strategy out there

What did humans actually evolve to eat? With paleo, keto, vegan, Mediterranean, and a thousand other diets all claiming to be "the one," it's no wonder people feel whiplashed every time they walk into a grocery store. But what if the answer isn't found in the latest diet book, but in millions of years of human evolution?

Join Holly and Jim as they welcome back Harvard evolutionary biologist Dan Lieberman for a second appearance on the show. This time, Dan isn't talking exercise. He's talking food. Drawing on his new book, "Fed Up: What Evolution Reveals About Food, Diet, Health, and Eating Well," Dan explains why there's no single "evolutionary diet," why our supermarkets are a completely unprecedented environment for the human brain, and why willpower alone was never going to be enough. And because Dan doesn't just study diets, he lives them. He shares the surprisingly rough personal experiments he and his wife put themselves through in the name of research.

By the end of this episode, you'll understand exactly why eating well feels so hard in the modern world, and why that struggle has nothing to do with a lack of discipline.

Discussed on the episode:

• Why an evolutionary biologist says there's no such thing as "the" diet humans evolved to eat
• The "naturalistic fallacy" and why what our ancestors did isn't automatically what we should do
• What happened when Dan and his wife tried a raw food diet for several days (and why it ended with a bagel)
• The one natural food that's high in both sugar and fat, and what it reveals about why we crave certain foods
• How food processing quietly changed what's actually in your food, long before you ever open the package
• Why Dan calls modern ultra-processed foods "hyper-matched" to our brains
• The real reason low-carb and low-fat diets can both work, and why neither is right for everyone
• What Dan learned trying the Atkins diet as a self-described "carboholic"
• Why the Mediterranean diet keeps coming out on top, and whether that's fair to other traditional diets around the world
• His take on the vegan vs. carnivore debate, and why he wouldn't attempt one of them
• A listener's question about why the same diet can work great for one person and fail for their sibling
• Practical advice for eating well on a tight grocery budget
• The one thing Dan wants every listener to remember about their own struggles with food.

Resources mentioned:

• Dan Lieberman's book: "Fed Up: What Evolution Reveals About Food, Diet, Health, and Eating Well"

Most people trying to lose weight obsess over the what: what diet, what medication, what workout plan. But according to Holly and Jim, the real key to long-term success isn't found in any of those choices. It's found in a set of decisions most people never even realize they're making.

In this episode, Holly and Jim count down the 10 decisions that determine whether a weight loss journey actually sticks. Some are questions you'd expect. Others might catch you completely off guard, including the one they say most listeners will never predict is number one.

Whether you're just starting, deep into a GLP-1 medication, working to maintain weight you've already lost, or wondering if you're on the right plan at all, this countdown is built for you. So before you make your next move, find out if you've quietly been making these decisions by default or on purpose.

Discussed on the episode:

• The very first decision Holly says most people skip entirely and why it might surprise you coming from two people who host a weight loss podcast.
• Why a number on the scale might not mean what you think it means, and what "success" should really be measured by
• A newer, often-overlooked decision that's only become critical in the age of powerful weight loss medications
• The mindset shift that separates people who keep weight off from those who regain it
• Why hitting a plateau might actually be a sign you're succeeding, not failing.
• The surprising, deeply personal decision Holly and Jim rank as number one one they say most listeners will guess wrong

For years, the ceiling on medical weight loss was 15%, maybe 20% if you were lucky. Now a new triple-target medication is posting average results that flirt with 30% body weight loss in clinical trials, numbers once reserved for the operating room. Holly and Jim sat down to unpack what's driving these results, and found themselves asking a question neither expected to ask in their careers: how much weight loss is actually too much?

Retatrutide, the drug at the center of this episode, adds a third receptor target to the GLP-1 and GIP combination already familiar to listeners. Holly and Jim break down what this third piece brings to the table, walk through the newest published and presented trial data, and get refreshingly honest about the parts of this "medical miracle" that keep them up at night.

More weight loss isn't automatically better weight loss. As these medications get more powerful, Holly and Jim argue the field needs to catch up fast on nutrition, dosing, and what "success" even means going forward. If you've been following the GLP-1 story, this episode is the plot twist you didn't see coming.

Discussed on the episode:

• What makes this new medication a "triple agonist," and why adding a hormone best known for raising blood sugar might actually help with weight loss.
• The eye-opening trial results that have researchers using words like "mind-blowing" and why the number didn't plateau the way older treatments do
• A surprising new clinical worry that Holly never thought she'd hear herself say out loud
• Why "maximum dose" might not be the right goal for most people, even though it produces the biggest numbers
• The uncomfortable side effect that showed up more with this medication than with anything else on the market
• Whether switching medications is a good idea if what you're currently using is already working.
• The philosophical question Holly and Jim now find themselves asking about appetite itself and why silencing it completely might not be a win.
• A hint at what's coming next in obesity treatment, involving a hormone that hasn't entered the conversation yet